Discover

SUPN
Supernus Pharmaceuticals, Inc.
42.00
2 x 33.83
2 x 56.00
bid
ask
-
0.92
2.14%
2 @ 07:30 PM
42.00 +0.00 (0.01%)
Ytd-15.49%
1y-8.95%
41.62
day range
42.89
41.28
52 week range
57.00
Open42.89Prev Close42.92Low41.62High42.89Mkt Cap2.45B
Vol1.18MAvg Vol843.05KEPS-1.92P/EN/AForward P/E9.42
Beta0.56Short Ratio4.69Inst. Own106.35%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0350-d Avg45.74200-d Avg48.361yr Est61.75

SUPN News

Supernus Pharmaceuticals to Participate in September Investor Conferences
globenewswire.com
Supernus Pharmaceuticals to Participate in September Investor Conferences

ROCKVILLE, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a

Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD
globenewswire.com
Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help E

ROCKVILLE, Md., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Professional snowboarder, Chloe Kim, is partnering

SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
gurufocus.com
SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtain

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Supernus Pharmaceuticals

SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtain

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale

BlackRock Inc. Purchases New Position in Supernus Pharmaceuticals, Inc. $SUPN
defenseworld.net
BlackRock Inc. Purchases New Position in Supernus Pharmaceuticals, Inc. $SUPN

BlackRock Inc. purchased a new position in Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the unde

Is the Options Market Predicting a Spike in Supernus Pharmaceuticals Stock?
zacks.com
Is the Options Market Predicting a Spike in Supernus Pharmaceuticals Stock?

Investors need to pay close attention to SUPN stock based on the movements in the options market lat

Critical Survey: Vectura Group (OTCMKTS:VEGPF) versus Supernus Pharmaceuticals (NASDAQ:SUPN)
defenseworld.net
Critical Survey: Vectura Group (OTCMKTS:VEGPF) versus Supernus Pharmaceuticals (NASDAQ:SUPN)

Supernus Pharmaceuticals (NASDAQ: SUPN - Get Free Report) and Vectura Group (OTCMKTS:VEGPF - Get Fre

Allworth Financial LP Invests $2.36 Million in Supernus Pharmaceuticals, Inc. $SUPN
defenseworld.net
Allworth Financial LP Invests $2.36 Million in Supernus Pharmaceuticals, Inc. $SUPN

Allworth Financial LP acquired a new position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ: S

Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
zacks.com
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026

INDV's proposed Supernus merger could broaden its CNS portfolio, cut costs and reduce reliance on Su

Supernus Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript
benzinga.com
Supernus Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript

Supernus Pharmaceuticals (NASDAQ:SUPN) held its second-quarter earnings conference call on Tuesday.

Supernus Pharmaceuticals, Inc. $SUPN Shares Purchased by Bank of America Corp DE
defenseworld.net
Supernus Pharmaceuticals, Inc. $SUPN Shares Purchased by Bank of America Corp DE

Bank of America Corp DE lifted its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

Supernus Pharmaceuticals, Inc. $SUPN Shares Sold by Assenagon Asset Management S.A.
defenseworld.net
Supernus Pharmaceuticals, Inc. $SUPN Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lessened its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ: SUP

California State Teachers Retirement System Grows Stock Holdings in Supernus Pharmaceuticals, Inc. $SUPN
defenseworld.net
California State Teachers Retirement System Grows Stock Holdings in Supernus Pharmaceuticals, Inc. $

California State Teachers Retirement System lifted its stake in Supernus Pharmaceuticals, Inc. (NASD

Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders?
prnewswire.com
Are BOW, ATKR, SUPN Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?
zacks.com
SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical - Generic Drugs stocks have likely encountered both Supernus P

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
gurufocus.com
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and P

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swic

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN
businesswire.com
Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and P

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

New Strong Buy Stocks for August 7th
zacks.com
New Strong Buy Stocks for August 7th

EDRY, OPBK, SUPN, MSBI and NXRT have been added to the Zacks Rank #1 (Strong Buy) List on August 7th

Best Value Stocks to Buy for August 7th
zacks.com
Best Value Stocks to Buy for August 7th

BCAL, SUPN and NXRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 7th, 2026.

INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
zacks.com
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook

Indivior announces a merger with Supernus to form a CNS-focused biopharma company, tops Q2 earnings

Top 3 Health Care Stocks You'll Regret Missing This Quarter
benzinga.com
Top 3 Health Care Stocks You'll Regret Missing This Quarter

The most oversold health care stocks present a buying opportunity. RSI indicator compares stock stre

Why Supernus Pharmaceuticals Stock Topped the Market Today
fool.com
Why Supernus Pharmaceuticals Stock Topped the Market Today

The two companies will carry the Supernus name. Supernus also published its latest quarterly earning

Supernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue
benzinga.com
Supernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in

Supernus and Indivior agree to merge in an all-stock deal, targeting $2.2 billion in revenue and $12

benzinga.com
UPDATE: Supernus Pharmaceuticals Q2 Adj. EPS $0.53 Beats $0.42 Estimate

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly earnings of $0.53 per share which beat the

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 121.2% to $6.99 during Monday'

benzinga.com
Supernus Pharmaceuticals To Merge With Indivior Pharmaceuticals; SUPN Stockholders Will Receive 1.54

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today

benzinga.com
Cantor Fitzgerald Maintains Overweight on Supernus Pharmaceuticals, Raises Price Target to $67

Cantor Fitzgerald analyst Kristen Kluska maintains Supernus Pharmaceuticals (NASDAQ:SUPN) with a

Supernus Pharmaceuticals Q1 2026 Earnings Call Transcript
benzinga.com
Supernus Pharmaceuticals Q1 2026 Earnings Call Transcript

benzinga.com
Supernus Pharmaceuticals Affirms FY2026 Sales Guidance of $840.000M-$870.000M vs $862.242M Est

Supernus Pharmaceuticals (NASDAQ:SUPN) affirms FY2026 sales outlook from $840.000 million-$870.000 m

benzinga.com
Supernus Pharmaceuticals Q1 EPS $(0.04) Misses $(0.01) Estimate, Sales $207.705M Beat $192.918M Esti

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly losses of $(0.04) per share which missed t

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Earnings Scheduled For February 24, 2026
benzinga.com
Earnings Scheduled For February 24, 2026

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

benzinga.com
10 Health Care Stocks Whale Activity In Today's Session

Crowdstrike To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday
benzinga.com
Crowdstrike To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Thursday

benzinga.com
Earnings Scheduled For August 5, 2025

benzinga.com
Earnings Scheduled For May 6, 2025

benzinga.com
Earnings Scheduled For February 25, 2025

This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
benzinga.com
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Gentherm Posts Downbeat Results, Joins Celanese, Bumble And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Gentherm Posts Downbeat Results, Joins Celanese, Bumble And Other Big Stocks Moving Lower In Wednesd

Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

benzinga.com
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday

benzinga.com
Earnings Scheduled For February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

benzinga.com
Earnings Scheduled For November 8, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 647 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 369 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday's session, 275 companies made new 52-week lows.